Dr Mandy Miresmaeili has a rich multidisciplinary background in pharmaceutical science. She initially graduated with a Doctor of Pharmacy (Pharm.D) and has consistently pursued excellence and innovation in the field. Building on this foundation, Dr. Miresmaeili pursued a Master’s in Genomic Medicine from King's College London. This specialised training provided her with profound insights into precision medicine, enhancing her ability to tailor medical treatments to patients' unique genetic profiles.

Currently, Dr Miresmaeili is involved in a clinical trial study at Guy's and St Thomas' NHS Foundation Trust, investigating the impact of patient genomes on the liver metabolism of a novel cardiovascular drug. Parallel to her clinical accomplishment, Dr. Miresmaeili serves as a research fellow at the Institute of Psychiatry, Psychology & Neuroscience (IoPNN) at King's College London. Her research focuses on developing a comprehensive penetrance panel for common variants linked to neurodegenerative diseases, aiming to advance personalised genetic counselling.

Recognised for her contributions to health research, Dr Miresemaeili has been awarded a fellowship of the National Institute for Health and Care Research (NIHR). She is poised to further extend her expertise by pursuing another degree in Applied Statistical Modelling and Health Informatics at King's College London. This upcoming academic venture aims to integrate her extensive knowledge in pharmaceuticals and medicine with machine learning techniques, ultimately improving human health by tailoring medical interventions to individual needs.

Research interests

• Personalised Medicine
• Genomics
• Bioinformatics
• Machine learning
• Cardiovascular diseases
• Neurodegenerative diseases

Expertise and public engagement

• Fellowship awardee of the National Institute for Health and Care Research (NIHR)
• Member of the Royal Pharmaceutical Society (RPS)
• Best Pharmacy Practice Award for exceptional contributions during the COVID-19 outbreaks